Telescope Innovations Corp. (TELI.CN)

CAD 0.27

(1.89%)

Revenue Summary of Telescope Innovations Corp.

  • Telescope Innovations Corp.'s latest annual revenue in 2022 was 595.39 Thousand CAD , down 0.0% from previous year.
  • Telescope Innovations Corp.'s latest quarterly revenue in 2023 Q3 was 1.01 Million CAD , up 24.09% from previous quarter.
  • Telescope Innovations Corp. reported a annual revenue of - CAD in annual revenue 2021, down 0.0% from previous year.
  • Telescope Innovations Corp. reported a annual revenue of - CAD in annual revenue 2020, down 0.0% from previous year.
  • Telescope Innovations Corp. reported a quarterly revenue of 816.32 Thousand CAD for 2023 Q2, up 59.73% from previous quarter.
  • Telescope Innovations Corp. reported a quarterly revenue of 511.06 Thousand CAD for 2023 Q1, down -14.16% from previous quarter.

Annual Revenue Chart of Telescope Innovations Corp. (2022 - 2020)

Historical Annual Revenue of Telescope Innovations Corp. (2022 - 2020)

Year Revenue Revenue Growth
2022 595.39 Thousand CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%

Peer Revenue Comparison of Telescope Innovations Corp.

Name Revenue Revenue Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc 21.14 Thousand CAD -2716.452%
BetterLife Pharma Inc. - CAD -Infinity%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. - CAD -Infinity%
Rapid Dose Therapeutics Corp. 1.02 Million CAD 41.652%
Defence Therapeutics Inc. - CAD -Infinity%
Entheon Biomedical Corp. 250.32 Thousand CAD -137.852%
Gemina Laboratories Ltd. - CAD -Infinity%
Glow Lifetech Corp. 43.93 Thousand CAD -1255.303%
Lexston Life Sciences Corp. - CAD -Infinity%
Pharmala Biotech Holdings Inc. 532 Thousand CAD -11.916%
Doseology Sciences Inc. 98.52 Thousand CAD -504.33%
MYND Life Sciences Inc. - CAD -Infinity%
Nova Mentis Life Science Corp. 28.34 Thousand CAD -2000.466%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. - CAD -Infinity%